ShareValue.ai

ShareValue scores for 603309.SHG: Valuation 56, Quality 59, Growth 37, Health 43.

Well Lead Med Co Ltd logo

603309.SHG
SSE

Well Lead Med Co Ltd

CN¥11.44(+3.44%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 16%
Valuation
56
Fair Value
Price vs Value
Quality
59
Moderate
Business Strength
Growth
37
Weak
Revenue & Earnings
Health
43
Moderate
Financial Stability
Momentum
35
Bearish
Price Trend

Company Details

About

Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in urology, endourology, anaesthesia, respiratory, hemodialysis, and pain management areas worldwide. It provides urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guide wires, ureteral stent, urethral and ureteral dilation, and stone retrieval basket; anesthesia products, comprising endotracheal tubes, intubation accessories, laryngeal masks, endobronchial and tracheostomy tubes, anesthesia breathing circuits and accessories, and nasopharyngeal and oropharyngeal airway products. The company also offers respiratory products, including oxygen and aerosol therapy products, and capnography mask and cannula products; drainage/suction/gastroenterology products, such as drainage systems, Yankauer handles, suction catheters, and stomach and feeding tubes; hemodialysis blood tubing set; home care products, including male external catheter and convicath intermittent catheter; and ambulatory infusion pump for pain management. Well Lead Medical Co., Ltd. was founded in 1998 and is based in Guangzhou, China.

Score Analysis

AI Investment Thesis

Data as of:Jun 29, 2026
|
Last calculated:Jun 29, 2026